Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism

Noritada Yoshikawa, Masao Nagasaki, Motoaki Sano, Satori Tokudome, Kazuko Ueno, Noriaki Shimizu, Seiya Imoto, Satoru Miyano, Makoto Suematsu, Keiichi Fukuda, Chikao Morimoto, Hirotoshi Tanaka

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Recent studies have documented various roles of adrenal corticosteroid signaling in cardiac physiology and pathophysiology. It is known that glucocorticoids and aldosterone are able to bind glucocorticoid receptor (GR) and mineralocorticoid receptor, and these ligand-receptor interactions are redundant. It, therefore, has been impossible to delineate how these nuclear receptors couple with corticosteroid ligands and differentially regulate gene expression for operation of their distinct functions in the heart. Here, to particularly define the role of GR in cardiac muscle cells, we applied a ligand-based approach involving the GR-specific agonist cortivazol (CVZ) and the GR antagonist RU-486 and performed microarray analysis using rat neonatal cardiomyocytes. We indicated that glucocorticoids appear to be a major determinant of GR-mediated gene expression when compared with aldosterone. Moreover, expression profiles of these genes highlighted numerous roles of glucocorticoids in various aspects of cardiac physiology. At first, we identified that glucocorticoids, via GR, induce mRNA and protein expression of a transcription factor Kruppel-like factor 15 and its downstream target genes, including branched-chain aminotransferase 2, a key enzyme for amino acid catabolism in the muscle. CVZ treatment or overexpression of KLF15 decreased cellular branched-chain amino acid concentrations and introduction of small-interfering RNA against KLF15 cancelled these CVZ actions in cardiomyocytes. Second, glucocorticoid-GR signaling promoted gene expression of the enzymes involved in the prostaglandin biosynthesis, including cyclooxygenase-2 and phospholipase A2 in cardiomyocytes. Together, we may conclude that GR signaling should have distinct roles for maintenance of cardiac function, for example, in amino acid catabolism and prostaglandin biosynthesis in the heart.

Original languageEnglish
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume296
Issue number6
DOIs
Publication statusPublished - 2009 Jun

Fingerprint

Glucocorticoid Receptors
Gene Expression Profiling
Ligands
Glucocorticoids
Cardiac Myocytes
Aldosterone
Gene Expression
Prostaglandins
Adrenal Cortex Hormones
Kruppel-Like Transcription Factors
Amino Acids
Mineralocorticoid Receptors
Mifepristone
Branched Chain Amino Acids
Phospholipases A2
Enzymes
Cyclooxygenase 2
Microarray Analysis
Cytoplasmic and Nuclear Receptors
Transcriptome

Keywords

  • Cardiovascular system
  • Cylooxygenase-2
  • Endocrinology
  • KLF15
  • Phospholipase A2

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Endocrinology, Diabetes and Metabolism

Cite this

Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism. / Yoshikawa, Noritada; Nagasaki, Masao; Sano, Motoaki; Tokudome, Satori; Ueno, Kazuko; Shimizu, Noriaki; Imoto, Seiya; Miyano, Satoru; Suematsu, Makoto; Fukuda, Keiichi; Morimoto, Chikao; Tanaka, Hirotoshi.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 296, No. 6, 06.2009.

Research output: Contribution to journalArticle

Yoshikawa, Noritada ; Nagasaki, Masao ; Sano, Motoaki ; Tokudome, Satori ; Ueno, Kazuko ; Shimizu, Noriaki ; Imoto, Seiya ; Miyano, Satoru ; Suematsu, Makoto ; Fukuda, Keiichi ; Morimoto, Chikao ; Tanaka, Hirotoshi. / Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism. In: American Journal of Physiology - Endocrinology and Metabolism. 2009 ; Vol. 296, No. 6.
@article{1a17549b8bff4cf78753352b2b2a64b3,
title = "Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism",
abstract = "Recent studies have documented various roles of adrenal corticosteroid signaling in cardiac physiology and pathophysiology. It is known that glucocorticoids and aldosterone are able to bind glucocorticoid receptor (GR) and mineralocorticoid receptor, and these ligand-receptor interactions are redundant. It, therefore, has been impossible to delineate how these nuclear receptors couple with corticosteroid ligands and differentially regulate gene expression for operation of their distinct functions in the heart. Here, to particularly define the role of GR in cardiac muscle cells, we applied a ligand-based approach involving the GR-specific agonist cortivazol (CVZ) and the GR antagonist RU-486 and performed microarray analysis using rat neonatal cardiomyocytes. We indicated that glucocorticoids appear to be a major determinant of GR-mediated gene expression when compared with aldosterone. Moreover, expression profiles of these genes highlighted numerous roles of glucocorticoids in various aspects of cardiac physiology. At first, we identified that glucocorticoids, via GR, induce mRNA and protein expression of a transcription factor Kruppel-like factor 15 and its downstream target genes, including branched-chain aminotransferase 2, a key enzyme for amino acid catabolism in the muscle. CVZ treatment or overexpression of KLF15 decreased cellular branched-chain amino acid concentrations and introduction of small-interfering RNA against KLF15 cancelled these CVZ actions in cardiomyocytes. Second, glucocorticoid-GR signaling promoted gene expression of the enzymes involved in the prostaglandin biosynthesis, including cyclooxygenase-2 and phospholipase A2 in cardiomyocytes. Together, we may conclude that GR signaling should have distinct roles for maintenance of cardiac function, for example, in amino acid catabolism and prostaglandin biosynthesis in the heart.",
keywords = "Cardiovascular system, Cylooxygenase-2, Endocrinology, KLF15, Phospholipase A2",
author = "Noritada Yoshikawa and Masao Nagasaki and Motoaki Sano and Satori Tokudome and Kazuko Ueno and Noriaki Shimizu and Seiya Imoto and Satoru Miyano and Makoto Suematsu and Keiichi Fukuda and Chikao Morimoto and Hirotoshi Tanaka",
year = "2009",
month = "6",
doi = "10.1152/ajpendo.90767.2008",
language = "English",
volume = "296",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism

AU - Yoshikawa, Noritada

AU - Nagasaki, Masao

AU - Sano, Motoaki

AU - Tokudome, Satori

AU - Ueno, Kazuko

AU - Shimizu, Noriaki

AU - Imoto, Seiya

AU - Miyano, Satoru

AU - Suematsu, Makoto

AU - Fukuda, Keiichi

AU - Morimoto, Chikao

AU - Tanaka, Hirotoshi

PY - 2009/6

Y1 - 2009/6

N2 - Recent studies have documented various roles of adrenal corticosteroid signaling in cardiac physiology and pathophysiology. It is known that glucocorticoids and aldosterone are able to bind glucocorticoid receptor (GR) and mineralocorticoid receptor, and these ligand-receptor interactions are redundant. It, therefore, has been impossible to delineate how these nuclear receptors couple with corticosteroid ligands and differentially regulate gene expression for operation of their distinct functions in the heart. Here, to particularly define the role of GR in cardiac muscle cells, we applied a ligand-based approach involving the GR-specific agonist cortivazol (CVZ) and the GR antagonist RU-486 and performed microarray analysis using rat neonatal cardiomyocytes. We indicated that glucocorticoids appear to be a major determinant of GR-mediated gene expression when compared with aldosterone. Moreover, expression profiles of these genes highlighted numerous roles of glucocorticoids in various aspects of cardiac physiology. At first, we identified that glucocorticoids, via GR, induce mRNA and protein expression of a transcription factor Kruppel-like factor 15 and its downstream target genes, including branched-chain aminotransferase 2, a key enzyme for amino acid catabolism in the muscle. CVZ treatment or overexpression of KLF15 decreased cellular branched-chain amino acid concentrations and introduction of small-interfering RNA against KLF15 cancelled these CVZ actions in cardiomyocytes. Second, glucocorticoid-GR signaling promoted gene expression of the enzymes involved in the prostaglandin biosynthesis, including cyclooxygenase-2 and phospholipase A2 in cardiomyocytes. Together, we may conclude that GR signaling should have distinct roles for maintenance of cardiac function, for example, in amino acid catabolism and prostaglandin biosynthesis in the heart.

AB - Recent studies have documented various roles of adrenal corticosteroid signaling in cardiac physiology and pathophysiology. It is known that glucocorticoids and aldosterone are able to bind glucocorticoid receptor (GR) and mineralocorticoid receptor, and these ligand-receptor interactions are redundant. It, therefore, has been impossible to delineate how these nuclear receptors couple with corticosteroid ligands and differentially regulate gene expression for operation of their distinct functions in the heart. Here, to particularly define the role of GR in cardiac muscle cells, we applied a ligand-based approach involving the GR-specific agonist cortivazol (CVZ) and the GR antagonist RU-486 and performed microarray analysis using rat neonatal cardiomyocytes. We indicated that glucocorticoids appear to be a major determinant of GR-mediated gene expression when compared with aldosterone. Moreover, expression profiles of these genes highlighted numerous roles of glucocorticoids in various aspects of cardiac physiology. At first, we identified that glucocorticoids, via GR, induce mRNA and protein expression of a transcription factor Kruppel-like factor 15 and its downstream target genes, including branched-chain aminotransferase 2, a key enzyme for amino acid catabolism in the muscle. CVZ treatment or overexpression of KLF15 decreased cellular branched-chain amino acid concentrations and introduction of small-interfering RNA against KLF15 cancelled these CVZ actions in cardiomyocytes. Second, glucocorticoid-GR signaling promoted gene expression of the enzymes involved in the prostaglandin biosynthesis, including cyclooxygenase-2 and phospholipase A2 in cardiomyocytes. Together, we may conclude that GR signaling should have distinct roles for maintenance of cardiac function, for example, in amino acid catabolism and prostaglandin biosynthesis in the heart.

KW - Cardiovascular system

KW - Cylooxygenase-2

KW - Endocrinology

KW - KLF15

KW - Phospholipase A2

UR - http://www.scopus.com/inward/record.url?scp=66849128246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66849128246&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.90767.2008

DO - 10.1152/ajpendo.90767.2008

M3 - Article

VL - 296

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 6

ER -